U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines Guidance for Industry May 2007

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
2006D-0083
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research

This document is intended to provide to you, sponsors of seasonal inactivated influenza vaccines, guidance on clinical development approaches to support a Biologics License Application (BLA). The approaches in this guidance apply to both nonadjuvanted and adjuvanted hemagglutinin-based seasonal vaccines, including "split virus," subunit, and whole virus inactivated vaccines propagated in embryonated chicken eggs or cell-culture, and to recombinant hemagglutinin-based protein vaccines, and DNA vaccines that express hemagglutinin. This document does not address live attenuated influenza vaccines or influenza vaccines that do not rely on immunity to a hemagglutinin component.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: 2006D-0083.

Questions?

 
Back to Top